Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Nippon Shinyaku
Welcome,
Profile
Billing
Logout
24 Products
124 Diseases
24 Products
340 Trials
12779 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
37
74
111
148
185
222
259
296
333
370
Gazyva
(obinutuzumab) / Roche, Biogen
Vyxeos
(cytarabine/daunorubicin liposomal formulation) / Jazz
Opsumit
(macitentan) / Nippon Shinyaku, J&J
Jaypirca
(pirtobrutinib) / Eli Lilly
Emcyt
(estramustine) / Pfizer, Nippon Shinyaku
Uptravi
(selexipag) / J&J
Fintepla
(low-dose fenfluramine) / UCB
Campral EC
(acamprosate delayed release) / EMD Serono, Nippon Shinyaku
Elzonris
(tagraxofusp-erzs) / Menarini
Amnolake
(tamibarotene) / Rege Nephro
buloxibutid
(C21) / Vicore Pharma
deramiocel
(CAP-1002) / Capricor, Lonza, Nippon Shinyaku
Viltepso
(viltolarsen) / Nippon Shinyaku, National Center of Neurology and Psychiatry
tadekinig alfa
(IL-18BP) / AB2 Bio, Nippon Shinyaku
radgocitabine
(DFP-10917) / Delta-Fly Pharma
Uptravi Injection
(selexipag IV) / J&J
brogidirsen
(NS-089/NCNP-02) / Nippon Shinyaku, National Center of Neurology and Psychiatry
clemidsogene lanparvovec
(RGX-121) / REGENXBIO, Nippon Shinyaku
ilginatinib
(NS-018) / Nippon Shinyaku
RGX-111
/ REGENXBIO, Nippon Shinyaku
NS-229
/ Nippon Shinyaku
NS-580
/ Nippon Shinyaku
afacifenacin fumarate
(SMP-986) / Sumitomo Pharma, Nippon Shinyaku
